A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer.

654 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Cancer active targeting by nanoparticles: a comprehensive review of literature (2014, methodology): “Employing a similar strategy, Kim et al. (Kim et al. 2010) targeted gold nanoparticles using an aptamer that binds to PSMA.”
Algae as crucial organisms in advancing nanotechnology: a systematic review (2016, methodology): “In medical application they have been used for targeting in computed tomography and in cancer therapy (Kim et al. 2010).”
Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (2014, background): “A9 CGA aptamer Gold NPs PSMA Prostate cancer [240]”
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy (2012, background): “designed a CG-rich duplex containing PSMA aptamer-conjugated GNPs and magnetic nanoparticles as a prostate tumor targeting theranostic agent [156, 123].”